Director's Dealings ASCENDIS HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2008/005856/06) ISIN: ZAE000185005 Share code: ASC (“Ascendis” or “the Company”) Dealings in securities by directors In terms of paragraphs 3.63 to 3.65 of the JSE Limited (“the JSE”) Listings Requirements ("the Listings Requirements"), the following information, relating to dealings in securities by directors, is disclosed: Directors: Gary John Shayne and Crispian Dillon Nature of the transaction: Following on from the Ascendis SENS announcement released on 7 November 2014 pertaining to the capital raise of the Company, Coast2Coast Investments Proprietary Limited (“C2C”) participated in the secondary placement by way of a minor sell down of its shareholding in the Company, which equates to a decrease of its shareholding in Ascendis by c.4%, which was motivated to facilitate ancillary opportunities. Gary Shayne holds an 85% indirect interest in C2C and Crispian Dillon holds a 15% indirect interest in C2C. Number of shares: 5,734,000 Selling price per share: R15.00 Value: R86,010,000 Date of transaction: 7 November 2014 Class of shares: Ordinary shares Nature of transaction: Sale, off market Nature of interest: Direct Beneficial Written clearance obtained: Clearance was obtained from the Chairman of the Board 7 November 2014 Johannesburg Sponsor Investec Bank Limited Date: 07/11/2014 03:10:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.